[Role of serum Golgi protein 73 in the assessment of pathological prognosis and its inflammatory influencing factors for hepatitis B virus-related liver fibrosis] [0.03%]
血清高尔基体蛋白73在乙肝相关肝纤维化病理预后评估及其炎症影响因素中的作用
H N Fan,Y Q Ma,X Sun et al.
H N Fan et al.
Objective: To explore the predictive role of dynamic changes in serum Golgi protein 73 (GP73) and its inflammatory influencing factors on the reversal of hepatitis B virus-related liver fibrosis. Methods: Two hundred and seventy-eight patie...
[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B] [0.03%]
《加拿大肝病协会2025年慢性乙型肝炎管理指南关键更新要点介绍》
H Zhuang
H Zhuang
The Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada developed jointly the 2025 guidelines for the management of chronic hepatitis B in May 2025. The guidelines updated re...
[Introduction to the update points of the 2025 European Association for the Study of Liver clinical practice guidelines for the management of chronic hepatitis B infection] [0.03%]
[2025年欧洲肝脏研究协会慢性乙型肝炎感染管理临床实践指南更新要点介绍]
H Zhuang
H Zhuang
The European Association for the Study of Liver (EASL) on May 8, 2025, published the updated clinical practice guidelines for the management of chronic hepatitis B virus infection (HBV), which proposes a comprehensive, evidence-based approa...
[Expert consensus on the diagnosis and therapy of inherited hyperbilirubinemia (version 2025)] [0.03%]
遗传性高胆红素血症诊断和治疗专家共识(2025版)
Inherited Metabolic Liver Disease Collaboration Group, Chinese Society of Hepatology, Chinese Medical Association
Inherited Metabolic Liver Disease Collaboration Group
The Inherited and Metabolic Liver Disease Cooperative Group of the Hepatology Branch of the Chinese Medical Association organized experts in the relevant field to formulate the Expert Consensus on the Diagnosis and Treatment of Inherited Hy...
[Expert consensus on the clinical application of gut microbiota transplant therapy in chronic liver disease (version 2025)] [0.03%]
[中国肝衰竭诊疗指南（2023年版）]
Liver Related Digestive Diseases Group, Chinese Society of Hepatology, Chinese Medical Association
Liver Related Digestive Diseases Group
The gut microbiota plays an important role in maintaining host health and liver function, and gut microbiota transplant (also known as fecal microbiota transplantation) has shown potential clinical benefits in the treatment of chronic liver...
[Clinical treatment controversies and progress in liver cirrhosis: an evidence-based medicine perspective from managing portal hypertension to preventing complications] [0.03%]
[肝硬化临床治疗争议与进展：基于证据医学的门脉高压管理与并发症防治角度]
Y F Yang,J J Wang,G W Chen et al.
Y F Yang et al.
Liver cirrhosis as the terminal stage of chronic liver disease has seen many new insights and advances in its treatment strategies and perspectives in recent years. However, there are still many controversies about cirrhotic portal hyperten...
[Metabolic associated fatty liver disease induced cirrhosis: epidemiology, risk factors, and new strategies for precise prevention and control] [0.03%]
代谢性肝病诱发的肝硬化：流行病学、危险因素及精准防控新策略
X Bai,Q Q Chen,J Li
X Bai
Cirrhosis caused by metabolic associated fatty liver disease (MAFLD) has become a major global health challenge. Genetics, metabolic disorders, viruses, and other factors jointly drive the progression of this disease. The development of hig...
[Exploring the advantages of traditional Chinese medicine and dual-anti therapy for liver cirrhosis] [0.03%]
探索中医药及双重抗病毒治疗肝硬化的优势
Y Q Li,Y Feng,X B Wang et al.
Y Q Li et al.
Liver cirrhosis is the terminal stage of chronic liver disease. Minimizing complications of liver cirrhosis and the occurrence of liver cancer has become an important goal for liver cirrhosis treatment. The primary etiology leading to liver...
[Clinical research progress in different stages of recompensated cirrhosis] [0.03%]
[不同代偿期肝硬化临床研究进展]
Y P Wang,X H Yang,H Y Cai et al.
Y P Wang et al.
The 2021 version of the Baveno Ⅶ consensus on portal hypertension and the 2023 guidelines from the European Association for the Study of the Liver define recompensated cirrhosis as the restoration and stabilization of liver function, impro...
[Establishment of a database for liver cancer ablation and its clinical research value] [0.03%]
肝癌消融数据库的建立及临床科研价值分析
Y C Luo,M L Lang,P Liang et al.
Y C Luo et al.
The liver cancer ablation specialized disease database is an important tool for interventional practitioners to collect data and conduct scientific research for patients. This article will exemplify the application of a database for liver c...